Literature DB >> 11698566

Ductal lavage for detection of cellular atypia in women at high risk for breast cancer.

W C Dooley1, B M Ljung, U Veronesi, M Cazzaniga, R M Elledge, J A O'Shaughnessy, H M Kuerer, D T Hung, S A Khan, R F Phillips, P A Ganz, D M Euhus, L J Esserman, B G Haffty, B L King, M C Kelley, M M Anderson, P J Schmit, R R Clark, F C Kass, B O Anderson, S L Troyan, R D Arias, J N Quiring, S M Love, D L Page, E B King.   

Abstract

BACKGROUND: Breast cancer originates in breast epithelium and is associated with progressive molecular and morphologic changes. Women with atypical breast ductal epithelial cells have an increased relative risk of breast cancer. In this study, ductal lavage, a new procedure for collecting ductal cells with a microcatheter, was compared with nipple aspiration with regard to safety, tolerability, and the ability to detect abnormal breast epithelial cells.
METHODS: Women at high risk for breast cancer who had nonsuspicious mammograms and clinical breast examinations underwent nipple aspiration followed by lavage of fluid-yielding ducts. All statistical tests were two-sided.
RESULTS: The 507 women enrolled included 291 (57%) with a history of breast cancer and 199 (39%) with a 5-year Gail risk for breast cancer of 1.7% or more. Nipple aspirate fluid (NAF) samples were evaluated cytologically for 417 women, and ductal lavage samples were evaluated for 383 women. Adequate samples for diagnosis were collected from 111 (27%) and 299 (78%) women, respectively. A median of 13,500 epithelial cells per duct (range, 43-492,000 cells) was collected by ductal lavage compared with a median of 120 epithelial cells per breast (range, 10-74,300) collected by nipple aspiration. For ductal lavage, 92 (24%) subjects had abnormal cells that were mildly (17%) or markedly (6%) atypical or malignant (<1%). For NAF, corresponding percentages were 6%, 3%, and fewer than 1%. Ductal lavage detected abnormal intraductal breast cells 3.2 times more often than nipple aspiration (79 versus 25 breasts; McNemar's test, P<.001). No serious procedure-related adverse events were reported.
CONCLUSIONS: Large numbers of ductal cells can be collected by ductal lavage to detect atypical cellular changes within the breast. Ductal lavage is a safe and well-tolerated procedure and is a more sensitive method of detecting cellular atypia than nipple aspiration.

Entities:  

Mesh:

Year:  2001        PMID: 11698566     DOI: 10.1093/jnci/93.21.1624

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  50 in total

Review 1.  Ductal lavage in the screening of high-risk women.

Authors:  Patrick J Kenney; Margarett C Ellison
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

Review 2.  Ductal lavage, nipple aspiration, and ductoscopy for breast cancer diagnosis.

Authors:  William C Dooley
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

Review 3.  Novel agents for chemoprevention, screening methods, and sampling issues.

Authors:  Mary Jo Fackler; Ella Evron; Seema A Khan; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

4.  The physiology of the normal human breast: an exploratory study.

Authors:  Dixie Mills; Eva J Gordon; Ashley Casano; Sarah Michelle Lahti; Tinh Nguyen; Alex Preston; Julie Tondre; Kuan Wu; Tiffany Yanase; Henry Chan; David Chia; Mahtash Esfandiari; Tiffany Himmel; Susan M Love
Journal:  J Physiol Biochem       Date:  2011-10-08       Impact factor: 4.158

Review 5.  Rating the risk factors for breast cancer.

Authors:  S Eva Singletary
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

6.  Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls.

Authors:  Angela J Fought; Claire McGathey; Denise M Scholtens; Richard E Heinz; Rick Lowe; Yvonne B Feeney; Oukseub Lee; Thomas E Kmiecik; Judith A Wolfman; Charles V Clevenger; Peter H Gann; Susan Gapstur; Robert T Chatterton; Seema A Khan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-18       Impact factor: 4.254

7.  Predictors of willingness to participate in window-of-opportunity breast trials.

Authors:  Kari B Wisinski; Adrienne Faerber; Stephanie Wagner; Thomas C Havighurst; Jane A McElroy; Kyungmann Kim; Howard H Bailey
Journal:  Clin Med Res       Date:  2013-04-11

8.  Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer.

Authors:  Karijn P M Suijkerbuijk; Elsken van der Wall; Helen Meijrink; Xiaojuan Pan; Inne H M Borel Rinkes; Margreet G E M Ausems; Paul J van Diest
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

9.  Status of Intraductal Therapy for Ductal Carcinoma in Situ.

Authors:  Meghan Flanagan; Susan Love; E Shelley Hwang
Journal:  Curr Breast Cancer Rep       Date:  2010-05-06

10.  Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer.

Authors:  Jennifer T Loud; Ellen Burke Beckjord; Kathryn Nichols; June Peters; Ruthann Giusti; Mark H Greene
Journal:  BMC Womens Health       Date:  2009-07-14       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.